Skip to content

Drug interactions

Mirtazapine + Pasireotide

Severity: Moderate

Mirtazapine and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can prolong the QT interval and cause bradycardia, and mirtazapine has been linked to QT prolongation, mainly in overdose or at-risk patients. Combined use may increase the risk of arrhythmia.

What this interaction means in plain words

Mirtazapine and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mirtazapine belongs to Central Nervous System; Pasireotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization, with pasireotide-induced bradycardia as a further risk factor.

What to do

Perform baseline and follow-up ECG monitoring and check potassium and magnesium. Avoid combining with further QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mirtazapine and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mirtazapine with Pasireotide?

MediHelp rates the interaction as moderate. Mirtazapine and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide can prolong the QT interval and cause bradycardia, and mirtazapine has been linked to QT prolongation, mainly in overdose or at-risk patients. Combined use may increase the risk of arrhythmia.

How serious is the interaction between Mirtazapine and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Perform baseline and follow-up ECG monitoring and check potassium and magnesium. Avoid combining with further QT-prolonging drugs.

What other medicines interact with Mirtazapine?

MediHelp also lists interactions of Mirtazapine with, for example, Isocarboxazid, Phenelzine, Pimozide. The full list is on the Mirtazapine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in